KROS compared with GOGO: revenue, margins and what each company keeps, and the suppliers and customers both name

KROSKeros Therapeutics, Inc.

Mkt capRevenueRevenue

GOGOGogo Inc.

Mkt capRevenueRevenue

Compare

KROSKeros Therapeutics, Inc.

GOGOGogo Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KROS

1 of 3at or beyond implied

Reportimpliedrealized× implied

Nov 6 '26—▼−0.95%—

Aug 4 '26±25.5%▲+1.38%×0.05

May 14 '26±32.2%▼−8.34%×0.26

Mar 5 '26±12.0%▼−14.96%×1.25

GOGO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 7 '26±12.8%▼−0.14%×0.01

May 8 '26±9.4%▼−5.78%×0.62

= impliedKROS realized, solidGOGO realized, hatchedOne scale, both sides: full bar = 33%× = |realized| ÷ impliedSource: market data

Mar 2 '26

±16.2%

▲+12.29%

×0.76

Nov 7 '25±10.9%▲+0.39%×0.04

KROSKeros Therapeutics, Inc.

9.31▼−1.50%· post 9.31

Mkt cap$183.7MRevenue$40MQ3 FY26Revenue$244MFY25

GOGOGogo Inc.

3.88▲+71.30%· post 3.98

ClosedNov 6 '26

Mkt cap$527.0MRevenue$213MQ3 FY26Revenue$910MFY25

Compare

ClosedNov 6 '26

KROSKeros Therapeutics, Inc.

GOGOGogo Inc.

9.31▼−1.50%post 9.31

Price

3.88▲+71.30%post 3.98

$183.7M

Mkt cap

$527.0M

Q3 FY26$40M

Revenue

$213MQ3 FY26

FY25$244M

Revenue

$910MFY25

KROS9.31▼−1.50%vsGOGO3.88▲+71.30%ClosedNov 6 '26